Analyst Ranking
Bottom 17%
#4678 out of 5563 analysts
Average Return
-3.26%
Win Rate
43%6 out of 14
Risk vs Reward
Poor
Good

Matt Larew's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
10x Genomics IncTXG
+168.82%$21.23$57.07
2026-03-31 -
2026-11-18
Buy
Charles River Laboratories International IncCRL
+77.63%$174.95$310.77
2025-10-06 -
2026-10-05
Buy
Ginkgo Bioworks Holdings IncDNA
+74.50%$30.44$7.76
2024-05-10 -
2025-05-09
Sell
Thermo Fisher Scientific IncTMO
+18.21%$498.29$589.04
2025-08-19 -
2026-08-18
Buy
Waters CorpWAT
+18.01%$394.97$466.10
2026-01-05 -
2026-11-18
Buy

Matt Larew Analyst Color

Get additional color on Matt Larew's coverage of popular stocks

Matt Larew's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Stevanato Group SpaSTVN
1HoldN/AN/ADowngrades
15 days ago
Option Care Health IncOPCH
1HoldN/AN/ADowngrades
a month ago
Revvity IncRVTY
1BuyN/AN/AInitiates Coverage On
a month ago
Bio Techne CorpTECH
2HoldN/AN/ADowngrades
5 months ago
10x Genomics IncTXG
1BuyN/AN/AUpgrades
8 months ago
Waters CorpWAT
1BuyN/AN/AInitiates Coverage On
10 months ago
Charles River Laboratories International IncCRL
1BuyN/AN/AUpgrades
a year ago
Thermo Fisher Scientific IncTMO
1BuyN/AN/AInitiates Coverage On
a year ago
Maxcyte IncMXCT
2HoldN/AN/ADowngrades
a year ago
Maravai Lifesciences Holdings IncMRVI
1HoldN/AN/ADowngrades
2 years ago
Amedisys IncAMED
1HoldN/AN/ADowngrades
2 years ago
Ginkgo Bioworks Holdings IncDNA
3SellN/AN/ADowngrades
3 years ago
Aptargroup IncATR
1BuyN/AN/AUpgrades
3 years ago
Avantor IncAVTR
1HoldN/AN/ADowngrades
3 years ago
Signify Health IncSGFY
2HoldN/AN/ADowngrades
4 years ago
Innovage Holding CorpINNV
2HoldN/AN/ADowngrades
5 years ago
Zymergen IncZY
2HoldN/AN/ADowngrades
5 years ago
Twist Bioscience CorpTWST
1BuyN/AN/AInitiates Coverage On
5 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.